TRDA

TRDA Deferred Revenue

$173.00KQuarterly · USD

Period ending:

TRDA FY Deferred RevenueUSD
TRDA FY Deferred Revenue2019-12-31: $0.002020-12-31: $0.002021-12-31: $0.002022-12-31: $0.002023-12-31: $132.26M2024-12-31: $13.65M2025-12-31: $342.00K$132.26M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TRDA deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Entrada Therapeutics Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
342,000
13,654,000
132,261,000
0
0
0
0

Compare deferred revenue

All TRDA financial metrics · TRDA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.